Speciality: Oncology
Description:
Welcome to our podcast. Today, we’re exploring how multidisciplinary teams play a vital role in modern cancer care. Cancer is a complex disease, and its treatment often requires input from various specialists. A multidisciplinary team brings together oncologists, surgeons, radiologists, pathologists, nurses, and other healthcare professionals. They collaborate to create a personalised treatment plan for each patient, considering every aspect of care—from diagnosis to treatment and follow-up support. This approach ensures that patients benefit from the combined expertise of the entire team, leading to better outcomes and improved quality of life. By working together, these teams help patients and families navigate the challenges of cancer treatment with greater confidence and support.
See More Webinars @ Hidoc Webinars
1.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
Mezigdomide Combinations Show Promise in Multiple Myeloma
4.
The risk of cancer is decreased by following international health recommendations.
5.
a cutting-edge cancer diagnostic tool.
1.
A Comprehensive Guide To Understanding Plasma Osmolality
2.
Case-Based Learning on Clonal Hematopoiesis With Unexpected Clinical Progression
3.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
4.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
5.
Case-Based Learning: Interpreting Unexpected Changes in Blood Counts During Longitudinal Clinical Follow-Up
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation